Amazon announced its intent to acquire One Medical in July 2022, and the $3.9 billion deal came under fire right away, with critics voicing their concerns about Amazon’s growing size and reach.

The company is pursuing treatments that could target diabetes and obesity in a pill form.

There are now more than 520 FDA-cleared AI algorithms and the majority are for radiology and cardiology, raising the question of who is liable if the AI gets something wrong.

The data, published in Clinical Imaging, reveal that more than 20% of respondents have witnessed scientific fraud within their department and more than 85% reported the issue of publication bias. 

Overall, hospital engagement in three domains of interoperability––receiving data, finding data and integrating data––have significantly increased since 2017.

The drops were linked to 55 reports of adverse events, including eye infections, permanent loss of vision and one death with a bloodstream infection.

A therapeutic oncology company has been cleared to market a cancer treatment that that turns a tumor’s own biology into a self-signaling target for radiation therapy.

The human author reviewing the article wrote about the benefits and inherent risks of utilizing AI in a medical publication setting, concluding that, overall, it could be “a powerful tool” used in the future of medical publishing—when used with caution.